Clinical Scorecard: Comparison of Transrectal and Transperineal Approaches in Prostate Fusion Biopsy: A Matched Analysis of Diagnostic Accuracy and Complications
At a Glance
Category
Detail
Condition
Prostate cancer diagnosis via MRI-targeted and systematic biopsy
Key Mechanisms
Transrectal (TR) and transperineal (TP) biopsy approaches using MRI fusion targeting; detection of clinically significant prostate cancer (csPCa) defined as ISUP grade group ≥ 2
Target Population
Men undergoing prostate biopsy for suspected prostate cancer with MRI lesions (PI-RADS ≥ 3)
Care Setting
European tertiary referral centers performing prostate biopsies
Key Highlights
TP biopsy shows higher detection rate of clinically significant prostate cancer (50.5% vs 36.2%) compared to TR biopsy in matched cohorts.
No significant difference in overall prostate cancer detection rates or biopsy-related complications between TP and TR approaches.
TP approach preferred for anterior and apical lesions and is recommended by European guidelines due to lower infectious risk.
Guideline-Based Recommendations
Diagnosis
European Association of Urology recommends transperineal systematic biopsies over transrectal due to lower infection risk.
MRI-targeted biopsy with fusion imaging is standard for detecting suspicious prostate lesions (PI-RADS ≥ 3).
Clinicians may use either transrectal or transperineal biopsy routes per American Urological Association guidelines.
Management
Antibiotic prophylaxis is routinely administered, especially in TR biopsies, to reduce infection risk.
TP biopsy preferred when subsequent focal therapies (cryotherapy, irreversible electroporation, targeted microwave ablation) are planned.
Systematic biopsy cores number tailored to prostate volume and urologist preference.
Monitoring & Follow-up
Monitor for post-biopsy complications including infections, acute urinary retention, and bleeding.
Follow-up imaging and pathology to confirm csPCa diagnosis and guide treatment.
Risks
Infectious complications are rare and comparable between TP and TR approaches in contemporary practice.
Mild bleeding and urinary retention occur at similar low rates in both biopsy methods.
Prior negative biopsy more common in TP group, indicating possible selection bias.
Patient & Prescribing Data
Men undergoing MRI-targeted and systematic prostate biopsy with suspicious lesions
Both TP and TR biopsy approaches are safe with low complication rates; TP biopsy yields higher detection of clinically significant prostate cancer, especially in anterior and apical lesions.
Clinical Best Practices
Use MRI fusion-guided biopsy with at least two targeted cores per lesion combined with systematic sampling.
Prefer transperineal biopsy for anterior/apical lesions and when planning focal therapy.
Administer antibiotic prophylaxis, particularly for transrectal biopsies, to minimize infection risk.
Perform pair-matched patient selection considering age, PSA, prostate volume, lesion size, and PI-RADS score to optimize diagnostic accuracy.
Monitor patients closely post-biopsy for infections, bleeding, and urinary retention despite low incidence.
by Marco Oderda, Romain Diamand, Rawad Abou Zahr, Julien Anract, Gregoire Assenmacher, Nicolas Barry Delongchamps, Alexandre Patrick Bui, Daniel Benamran, Giorgio Calleris, Charles Dariane, Mariaconsiglia Ferriero, Gaelle Fiard, Fayek Taha, Alexandre Fourcade, Georges Fournier, Karsten Guenzel, Adam Halinski, Giancarlo Marra, Guillaume Ploussard, Katerina Rysankova, Jean-Baptiste Roche, Giuseppe Simone, Olivier Windisch, Paolo Gontero
